Morgan Stanley Raises Welltower (WELL) Price Target on Strong Growth Outlook

Core Viewpoint - Welltower Inc. is recognized as one of the best real estate stocks to buy, reflecting strong confidence from hedge funds and analysts regarding its growth potential [1][9]. Financial Performance - In the fourth quarter, Welltower reported a revenue increase of 36%, EBITDA growth of 32%, and FFO per share rising by 22% [3]. - The company has strengthened its balance sheet by reducing leverage while investing in technology and personnel to support long-term growth [3]. Strategic Initiatives - Welltower launched its private funds management business and updated incentive programs for teams and operating partners [4]. - The company introduced the Tech Quad initiative to enhance technology capabilities and operational efficiency [4]. Investment Activity - Welltower completed nearly $11 billion in net investments, primarily focused on senior housing in high-growth markets [5]. - The company funded these investments largely through the $7.2 billion sale of its outpatient medical business, allowing a greater focus on senior housing [5]. - As of early 2026, Welltower has already completed or contracted $5.7 billion in acquisitions, with an additional $2.5 billion in potential deals [6]. Company Overview - Welltower Inc. is a healthcare real estate company specializing in senior housing and wellness communities across the U.S., U.K., and Canada, with a portfolio of over 2,000 properties [7].